Cargando…

A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds

The binding pockets of aminergic G protein‐coupled receptors are often targeted by drugs and virtual screening campaigns. In order to find ligands with unprecedented scaffolds for one of the best‐investigated receptors of this subfamily, the β(2)‐adrenergic receptor, we conducted a docking‐based scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Scharf, Magdalena M., Zimmermann, Mirjam, Wilhelm, Florian, Stroe, Raimond, Waldhoer, Maria, Kolb, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318225/
https://www.ncbi.nlm.nih.gov/pubmed/32301583
http://dx.doi.org/10.1002/cmdc.201900715
_version_ 1783550798138966016
author Scharf, Magdalena M.
Zimmermann, Mirjam
Wilhelm, Florian
Stroe, Raimond
Waldhoer, Maria
Kolb, Peter
author_facet Scharf, Magdalena M.
Zimmermann, Mirjam
Wilhelm, Florian
Stroe, Raimond
Waldhoer, Maria
Kolb, Peter
author_sort Scharf, Magdalena M.
collection PubMed
description The binding pockets of aminergic G protein‐coupled receptors are often targeted by drugs and virtual screening campaigns. In order to find ligands with unprecedented scaffolds for one of the best‐investigated receptors of this subfamily, the β(2)‐adrenergic receptor, we conducted a docking‐based screen insisting that molecules would address previously untargeted residues in extracellular loop 2. We here report the discovery of ligands with a previously undescribed coumaran‐based scaffold. Furthermore, we provide an analysis of the added value that X‐ray structures in different conformations deliver for such docking screens.
format Online
Article
Text
id pubmed-7318225
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73182252020-06-29 A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds Scharf, Magdalena M. Zimmermann, Mirjam Wilhelm, Florian Stroe, Raimond Waldhoer, Maria Kolb, Peter ChemMedChem Full Papers The binding pockets of aminergic G protein‐coupled receptors are often targeted by drugs and virtual screening campaigns. In order to find ligands with unprecedented scaffolds for one of the best‐investigated receptors of this subfamily, the β(2)‐adrenergic receptor, we conducted a docking‐based screen insisting that molecules would address previously untargeted residues in extracellular loop 2. We here report the discovery of ligands with a previously undescribed coumaran‐based scaffold. Furthermore, we provide an analysis of the added value that X‐ray structures in different conformations deliver for such docking screens. John Wiley and Sons Inc. 2020-04-17 2020-05-19 /pmc/articles/PMC7318225/ /pubmed/32301583 http://dx.doi.org/10.1002/cmdc.201900715 Text en © 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Full Papers
Scharf, Magdalena M.
Zimmermann, Mirjam
Wilhelm, Florian
Stroe, Raimond
Waldhoer, Maria
Kolb, Peter
A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title_full A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title_fullStr A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title_full_unstemmed A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title_short A Focus on Unusual ECL2 Interactions Yields β(2)‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds
title_sort focus on unusual ecl2 interactions yields β(2)‐adrenergic receptor antagonists with unprecedented scaffolds
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318225/
https://www.ncbi.nlm.nih.gov/pubmed/32301583
http://dx.doi.org/10.1002/cmdc.201900715
work_keys_str_mv AT scharfmagdalenam afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT zimmermannmirjam afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT wilhelmflorian afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT stroeraimond afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT waldhoermaria afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT kolbpeter afocusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT scharfmagdalenam focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT zimmermannmirjam focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT wilhelmflorian focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT stroeraimond focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT waldhoermaria focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds
AT kolbpeter focusonunusualecl2interactionsyieldsb2adrenergicreceptorantagonistswithunprecedentedscaffolds